Mitsubishi Chemical HoldingsKAITEKI Value for Tomorrow

Investor Center

Stock Quotes

TSE Filings

Feb. 06, 2020
Notice on Revision to Consolidated Financial Results Forecast
for the Fiscal Year Ending March 31, 2020  
Feb. 06, 2020
Consolidated Financial Information for the Third Quarter of the Fiscal Year Ending March 31, 2020  
Jan. 22, 2020
Taiyo Nippon Sanso Corporation Announces “Notice of Transition to a Holding Company Structure Through Company Split, Incorporation of a Subsidiary (Company-Split Preparation Company), and Partial Amendment to the Articles of Incorporation (Tradename Change)”  
Jan. 08, 2020
Announcement in Relation to Results of Tender Offer for Shares of Mitsubishi Tanabe Pharma Corporation (Securities Code: 4508)  
Nov. 18, 2019
Announcement of Commencement of Tender Offer for Shares of Mitsubishi Tanabe Pharma Corporation (Securities Code: 4508)  

IR News

Feb. 12, 2020
APTSIS 20 Current Status 
Oct. 03, 2019
KAITEKI Report 2019 
Jun. 26, 2019
Voting Results of the 14th Ordinary General Meeting of Shareholders 
Jun. 25, 2019
Notice of the Resolutions Adopted at the 14th Ordinary General Meeting of Shareholders 
May 30, 2019
Mitsubishi Chemical Holdings Corporation IR Day 2019 

IR Calendar

IR Calendar

To Our Individual Investors

To Our Individual Investors

Hitoshi Ochi,Representative Corporate Executive Officer,President & CEOHitoshi Ochi,Representative Corporate Executive Officer,President & CEO
Hitoshi Ochi,
Representative Corporate Executive Officer,
President & CEO

Latest IR Materials

Our latest financial results announcement, operating summary, and APTSIS 20 current status can be downloaded.

Contents

  • Operating Summary of 3Q-FY2019 (Feb. 2020)
  • Financial Results Announcement of 3Q-FY2019 (Feb. 2020)
  • APTSIS20 Current Status (Dec.2018)
  • Download

Related Information

  • News Releases
  • KAITEKI
  • Group Outline
  • Group Outline
  • Corporate Brochure